Precision Biotech
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
"AI-Screening" is an AI-powered biomedical interpretation system developed by Precision Biotech. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data-driven analytical recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation across medical institutions.
"BD-CARdio" is an ECG-AI interpretation system developed by Precision Biotech. It accelerates the generation of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data-driven analytical recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.
"BD-CARdio" is an ECG-AI interpretation system developed by Precision Biotech. It accelerates the generation of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data-driven analytical recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.
The content above was translated by Ai
Founded Year
2022
Unified Business No.
90138435
Status
Active
Number of Employees
0
Total Paid-in
Capital
5,100,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Precise Big Data develops the world's first medical-grade Edge AI chip platform, integrating biosignal analysis, AI inference, and hardware security for smart healthcare applications.
The content above was translated by Ai
